RE:RE:RE:RE:RE:Stock chartWell I'm glad you're starting to see the light. I get accused of slamming the stock but the reality is that I'm a concerned investor who doesn't just accept everything I'm fed by management or pumpers who pump with no facts to back up said pumps. I have a lot of money on the line here and it's up to me to do my own DD. When management says they are lining up institutional investors, I ask how and I get silence. That is never a good sign. They are always just feeding people what they want to hear and when you ask smart questions you get dumb answers. It is clear they don't have any plans and are flying by the seat of their pants. The only thing saving us is the science IMO. I'm just hoping that a major will come along and put an offer on the table before it's too late. How many stocks do you know that were held by nearly all retailers and they all walked away with big bucks. We need influencers and influencers hold huge positions and can force managements hands. Right now we have no one asking questions and just accepting status quo.
Stockfshr wrote: Interesting point on the ability of institutional investors to make sizeable investments. Sernova has too many shares already to want to do a pp at these low prices. And they will have all the cash they need for now with on hand, Evotec purchase and exercise of warrants. I suppose if the prospects are good enough institutions will find a way to invest but I agree with your comment on whether or not institutions will be interested in a mainly retail stock. You thought that an indication of institutions buying would be no price movement but heavy volume. Perhaps. But when that happens it is usually a sign of distribution. Not a good sign as people in the know are selling into the increased demand. I will hope increased demand, that also includes new retail, starts a steady upward progression in the stock price. A lot will depend on the FDA trial results June 6? We ain't the only game in town so these will be very important. Imho